Discover how ADAMAS secured a multi-year GxP partnership with a global biopharma company.
Resources
Rebuilding Momentum Through Consistent Engagement and Delivery
Discover how ADAMAS rebuilt momentum with a returning biopharma client through consistent engagement and delivery.
Expanding a Single Enquiry into a Multi-Year GxP Engagement
Discover how ADAMAS turned a single GxP enquiry into a multi-year quality partnership.
Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)
Watch the full on-demand session and gain practical insights into designing risk-based QA oversight under ICH E6 (R3).
Rescuing Clinical Studies Through Data-Driven Risk and QA Insight
Learn how analytics and early QA engagement help restore control and regulatory confidence.
ADAMAS Consulting’s AURA (Audit Universe Risk Assessment)
ADAMAS Consulting’s cutting-edge system incorporating automated risk algorithm technology, defining a new standard for Pharmacovigilance Risk Assessment
Key Updates in ICH E6(R3) & Implementation Steps Introduction
In this free guide, we break down the most critical updates to ICH E6(R3)—and provide practical, inspection-ready strategies to help you stay compliant, audit-ready, and ahead of regulatory expectations.
ADAMAS Consulting’s proven Risk-Based Quality Assurance (RBQA) process
ADAMAS Consulting’s proven Risk-Based Quality Assurance (RBQA) process—designed to help sponsors meet the evolving requirements of ICH E6 (R3) with confidence
GCP ICH E6 R3 Unveiled: Navigating the Evolving Roles of Sponsors and CROs
Discover how ICH E6(R3) is redefining sponsor and CRO roles in clinical trials. This webinar covers quality by design, risk-based approaches, and data governance, with expert insights and audience Q&A.
Target your risk where it lies: At the leading edge of risk-based strategy
Discover how ADAMAS helped a sponsor prepare for inspection using a targeted risk-based approach
Recent Posts
Clinical Quality Roundtable Series 2026 | USA
WEBINAR | “Designing Risk-Based QA Oversight for Clinical Trials Under ICH E6 (R3)”
Society of Quality Assurance (SQA) Annual Meeting 2026 | Maryland, USA
ICH E6 R3 — One Year On: From Regulatory Update to Operational Transformation
AURA: Revolutionizing Risk-Based Audit Planning in Pharmacovigilance